Lumen Technologies (LUMN) had the highest return between June 10, 2024 and August 28, 2024 by a mid-cap US stock, returning 321.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Lumen Technologies (LUMN) | 6/10/2024 - 8/28/2024 | 321.26% |
CommScope (COMM) | 6/10/2024 - 8/28/2024 | 161.49% |
Verona Pharma PLC ADR (VRNA) | 6/10/2024 - 8/28/2024 | 121.48% |
LandBridge Company LLC (LB) | 6/10/2024 - 8/28/2024 | 96.89% |
GDS (GDS) | 6/10/2024 - 8/28/2024 | 84.27% |
Ocular Therapeutix (OCUL) | 6/10/2024 - 8/28/2024 | 83.47% |
Regencell Bioscience (RGC) | 6/10/2024 - 8/28/2024 | 80.33% |
Mirum Pharmaceuticals (MIRM) | 6/10/2024 - 8/28/2024 | 78.55% |
Upstart Holdings (UPST) | 6/10/2024 - 8/28/2024 | 75.27% |
Trupanion (TRUP) | 6/10/2024 - 8/28/2024 | 67.75% |
ADMA Biologics (ADMA) | 6/10/2024 - 8/28/2024 | 67.05% |
Avidity Biosciences (RNA) | 6/10/2024 - 8/28/2024 | 66.85% |
Cinemark (CNK) | 6/10/2024 - 8/28/2024 | 66.57% |
Cellebrite DI (CLBT) | 6/10/2024 - 8/28/2024 | 61.23% |
Perimeter Solutions (PRM) | 6/10/2024 - 8/28/2024 | 60.31% |
Clear Secure (YOU) | 6/10/2024 - 8/28/2024 | 59.53% |
Veracyte (VCYT) | 6/10/2024 - 8/28/2024 | 56.46% |
Bancorp (TBBK) | 6/10/2024 - 8/28/2024 | 56.31% |
Sunrun (RUN) | 6/10/2024 - 8/28/2024 | 55.87% |
Sezzle Inc Common Stock (SEZL) | 6/10/2024 - 8/28/2024 | 55.13% |
Compass (COMP) | 6/10/2024 - 8/28/2024 | 54.55% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 6/10/2024 - 8/28/2024 | 54.06% |
Zeta Global (ZETA) | 6/10/2024 - 8/28/2024 | 52.61% |
Arcutis Biotherapeutics (ARQT) | 6/10/2024 - 8/28/2024 | 50.14% |
TG Therapeutics (TGTX) | 6/10/2024 - 8/28/2024 | 50.06% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
